Systematic review of available evidence on 11 high-priced inpatient orphan drugs.

Systematic review of available evidence on 11 high-priced inpatient orphan drugs.

Item
http://www.wikidata.org/entity/Q37116422
Systematic review on the evaluation criteria of orphan medicines in Central and Eastern European countriesEffectiveness, safety and costs of orphan drugs: an evidence-based reviewAtypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.Impact of orphan drugs on Latvian budget.Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries.Immunological Rare Diseases.Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis.Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study.Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases.
P2860

Systematic review of available evidence on 11 high-priced inpatient orphan drugs.

Item
http://www.wikidata.org/entity/Q37116422
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@en
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@nl
type
label
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@en
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@nl
prefLabel
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@en
Systematic review of available evidence on 11 high-priced inpatient orphan drugs.
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Systematic review of available evidence on 11 high-priced inpatient orphan drugs
@en
P2093
P275
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P932